Die Universität Ulm wurde 1967 als „Medizinisch-Naturwissenschaftliche Hochschule Ulm“ gegründet und ist die jüngste staatliche Universität in Baden-Württemberg. Die Universität hat zum Wintersemester 2019/20 rund 10.000 Studierende.

During the past decade, University of Ulm conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 5 clinical trials were completed, i.e. on average, 16.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Ulm" #1 sponsor was "University of Ulm" with 21 trials, followed by "Sharp HealthCare" with 4 trials sponsored, "AGO Study Group" with 3 trials sponsored, "Dr. med. Mahir Karakas" with 3 trials sponsored and "Heidelberg University" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Ulm" #1 collaborator was "University of Ulm" with 7 trials as a collaborator, "University College Cork" with 4 trials as a collaborator, "University of Alberta" with 3 trials as a collaborator, "B. Braun Melsungen AG" with 2 trials as a collaborator and "Children's Hospital Medical Center, Cincinnati" with 2 trials as a collaborator. Other collaborators include 114 different institutions and companies that were collaborators in the rest 100 trials.

According to Clinical.Site data, the most researched conditions in "University of Ulm" are "Coronary Artery Disease" (5 trials), "Amyotrophic Lateral Sclerosis" (4 trials), "Acute Myocardial Infarction" (3 trials), "Fallopian Tube Cancer" (3 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "University of Ulm" in a lesser frequency.

Most popular intervention types in "University of Ulm" are "Drug" (35 trials), "Procedure" (11 trials), "Other" (10 trials), "Device" (9 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "carboplatin" (3 trials), "Atrasentan" (2 trials), "CancerVax vaccine (CANVAXIN)" (2 trials) and "Setmelanotide" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Ulm" are 61 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Ulm". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in University of Ulm, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Ulm, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 17 trials that are defined as “Not Applicable".

University of Ulm has several departments that took part in Clinical trials: "Department of Neurology, University of Ulm" - 7 trials, "Department of Orthopaedic Trauma, University of Ulm" - 3 trials, "Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic" - 6 trials, "University Clinic Ulm, Department of Internal Medicine II" - 2 trials